At Novartis, we strive for economic achievement. We do so in a manner that brings value to society, is socially fair, environmentally sustainable, and respects and supports human rights within our sphere of influence.
Corporate citizenship is the right thing to do and makes good business sense. It is about responsible behavior and better business.
“Our customers want good products and they like a company with a desire to win in the marketplace. But we need to behave with integrity to keep our license to operate. If we don’t have a set of values – and live by them – the company won’t be successful.”
Dr. Daniel Vasella, Chairman and CEO, Novartis
Our approach ›
Corporate citizenship at Novartis follows a four-pillar approach, reflecting our commitment to patients, ethical business conduct, our people and communities, and environmental care.
Citizenship governance ›
We are committed to high standards of corporate governance, including managing citizenship.
Stakeholder engagement ›
Our integration of corporate citizenship into daily business activities acts as an 'inner moral compass' when we market pharmaceuticals.
UN Global Compact ›
We were among the first signatories to the Global Compact. Our Policy on Corporate Citizenship reflects the Compact's 10 principles.
Novartis Global Reporting Initiative (GRI) ›
We have been reporting against GRI indicators since 2004. Read our 2007 GRI report.
Awards and recognitions ›
Novartis received accolades in 2008 for its contributions to corporate citizenship.
Citizenship news ›
Find here a selection of our current and past citizenship news and features.
MedAdNews
Novartis has been named the "Most Admired Pharmaceutical Company."
Case studies
Code, policies and guidelines
Find here our Code of Conduct, citizenship-related policies and guidelines